{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T12:18:09Z","timestamp":1772367489662,"version":"3.50.1"},"reference-count":77,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2014,1,1]],"date-time":"2014-01-01T00:00:00Z","timestamp":1388534400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,1,1]],"date-time":"2014-01-01T00:00:00Z","timestamp":1388534400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia (FCT, Portugal)"},{"DOI":"10.13039\/501100000780","name":"European Union","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"crossref"}]},{"name":"QREN"},{"DOI":"10.13039\/501100008530","name":"FEDER","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100011929","name":"COMPETE","doi-asserted-by":"crossref","award":["SFRH\/BPD\/90010\/2012"],"award-info":[{"award-number":["SFRH\/BPD\/90010\/2012"]}],"id":[{"id":"10.13039\/501100011929","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Biochemistry"],"published-print":{"date-parts":[[2014,1]]},"DOI":"10.1016\/j.clinbiochem.2013.10.025","type":"journal-article","created":{"date-parts":[[2013,11,1]],"date-time":"2013-11-01T00:14:23Z","timestamp":1383264863000},"page":"8-15","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":39,"title":["Recent insights on the molecular mechanisms and therapeutic approaches for cardiac cachexia"],"prefix":"10.1016","volume":"47","author":[{"given":"Telma","family":"Martins","sequence":"first","affiliation":[]},{"given":"Rui","family":"Vitorino","sequence":"additional","affiliation":[]},{"given":"Daniel","family":"Moreira-Gon\u00e7alves","sequence":"additional","affiliation":[]},{"given":"Francisco","family":"Amado","sequence":"additional","affiliation":[]},{"given":"Jos\u00e9 Alberto","family":"Duarte","sequence":"additional","affiliation":[]},{"given":"Rita","family":"Ferreira","sequence":"additional","affiliation":[]}],"member":"78","reference":[{"key":"10.1016\/j.clinbiochem.2013.10.025_bb0005","first-page":"191","article-title":"Cardiac cachexia: pathophysiology and clinical implications","volume":"13","author":"Steinborn","year":"2003","journal-title":"Basic Appl Myology"},{"key":"10.1016\/j.clinbiochem.2013.10.025_bb0010","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.ijcard.2006.01.002","article-title":"Application of proteomics in cardiovascular medicine","volume":"108","author":"Lam","year":"2006","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.clinbiochem.2013.10.025_bb0015","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1136\/hrt.2002.007005","article-title":"Inflammatory mediators in chronic heart failure: An overview","volume":"90","author":"Anker","year":"2004","journal-title":"Heart"},{"key":"10.1016\/j.clinbiochem.2013.10.025_bb0020","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1007\/s00395-003-0433-8","article-title":"Tumour necrosis factor-\u03b1 and the failing heart: Pathophysiology and therapeutic implications","volume":"99","author":"von Haehling","year":"2004","journal-title":"Basic Res Cardiol"},{"key":"10.1016\/j.clinbiochem.2013.10.025_bb0025","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.cardiores.2006.08.018","article-title":"Nutrition, metabolism, and the complex pathophysiology of cachexia in chronic heart failure","volume":"73","author":"von Haehling","year":"2007","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.clinbiochem.2013.10.025_bb0030","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.cardiores.2006.01.013","article-title":"Autonomic imbalance and immune activation in chronic heart failure\u2014pathophysiological links","volume":"70","author":"Jankowska","year":"2006","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.clinbiochem.2013.10.025_bb0035","doi-asserted-by":"crossref","first-page":"505","DOI":"10.2174\/1389450033490948","article-title":"Aldosteronism in heart failure: A proinflammatory\/fibrogenic cardiac phenotype. Search for biomarkers and potential drug targets","volume":"4","author":"Weber","year":"2003","journal-title":"Curr Drug Targets"},{"key":"10.1016\/j.clinbiochem.2013.10.025_bb0040","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1080\/110264802753704064","article-title":"Imbalance of catabolic and anabolic pathways in chronic heart failure: Implications for the treatment of cardiac cachexia","volume":"46","author":"Anker","year":"2002","journal-title":"Scand J Nutr"},{"key":"10.1016\/j.clinbiochem.2013.10.025_bb0045","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/j.1527-5299.2002.00724.x","article-title":"Immune and neurohormonal pathways in chronic heart failure","volume":"8","author":"Sharma","year":"2002","journal-title":"Congestive Heart Fail"},{"key":"10.1016\/j.clinbiochem.2013.10.025_bb0050","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1016\/j.biocel.2005.04.017","article-title":"Insulin-like growth factor-1 and muscle wasting in chronic heart failure","volume":"37","author":"Schulze","year":"2005","journal-title":"Int J Biochem Cell Biol"},{"key":"10.1016\/j.clinbiochem.2013.10.025_bb0055","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s10741-006-9196-2","article-title":"Systemic inflammation in heart failure\u2014the whys and wherefores","volume":"11","author":"Yndestad","year":"2006","journal-title":"Heart Fail Rev"},{"key":"10.1016\/j.clinbiochem.2013.10.025_bb0060","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0167-5273(99)00186-2","article-title":"The role of inflammatory mediators in chronic heart failure: Cytokines, nitric oxide, and endothelin-1","volume":"72","author":"Sharma","year":"2000","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.clinbiochem.2013.10.025_bb0065","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1378\/chest.115.3.836","article-title":"Cardiac cachexia*a syndrome with impaired survival and immune and neuroendocrine activation","volume":"115","author":"Anker","year":"1999","journal-title":"Chest J"},{"key":"10.1016\/j.clinbiochem.2013.10.025_bb0070","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1007\/BF02696650","article-title":"Cachexia in chronic heart failure: Prognostic implications and novel therapeutic approaches","volume":"2","author":"Akashi","year":"2005","journal-title":"Curr Heart Fail Rep"},{"key":"10.1016\/j.clinbiochem.2013.10.025_bb0075","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.pharmthera.2008.09.009","article-title":"Cardiac cachexia: A systematic overview","volume":"121","author":"von Haehling","year":"2009","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.clinbiochem.2013.10.025_bb0080","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0167-5273(02)00233-4","article-title":"The syndrome of cardiac cachexia","volume":"85","author":"Anker","year":"2002","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.clinbiochem.2013.10.025_bb0085","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1016\/j.biocel.2005.03.013","article-title":"Muscle wasting in cardiac cachexia","volume":"37","author":"Strassburg","year":"2005","journal-title":"Int J Biochem Cell Biol"},{"key":"10.1016\/j.clinbiochem.2013.10.025_bb0090","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.clnu.2006.09.009","article-title":"Fat loss in cachexia\u2014is there a role for adipocyte lipolysis?","volume":"26","author":"Ryd\u00e9n","year":"2007","journal-title":"Clin Nutr"},{"key":"10.1016\/j.clinbiochem.2013.10.025_bb0095","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1053\/euhj.1998.1446","article-title":"Cytokines and neurohormones relating to body composition alterations in the wasting syndrome of chronic heart failure","volume":"20","author":"Anker","year":"1999","journal-title":"Eur Heart J"},{"key":"10.1016\/j.clinbiochem.2013.10.025_bb0100","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/j.nurpra.2011.04.018","article-title":"Cardiac cachexia","volume":"7","author":"Cavey","year":"2011","journal-title":"J Nurse Pract"},{"key":"10.1016\/j.clinbiochem.2013.10.025_bb0105","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1056\/NEJM199007263230405","article-title":"Elevated circulating levels of tumor necrosis factor in severe chronic heart failure","volume":"323","author":"Levine","year":"1990","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clinbiochem.2013.10.025_bb0110","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1136\/hrt.66.5.356","article-title":"Increased concentrations of tumour necrosis factor in \u201ccachectic\u201d patients with severe chronic heart failure","volume":"66","author":"McMurray","year":"1991","journal-title":"Br Heart J"},{"key":"10.1016\/j.clinbiochem.2013.10.025_bb0115","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1016\/S0735-1097(96)00268-9","article-title":"Circulating levels of cytokines and their endogenous modulators in patients with mild to severe congestive heart failure due to coronary artery disease or hypertension","volume":"28","author":"Testa","year":"1996","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.clinbiochem.2013.10.025_bb0120","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S0735-1097(97)00494-4","article-title":"Interleukin-6 spillover in the peripheral circulation increases with the severity of heart failure, and the high plasma level of interleukin-6 is an important prognostic predictor in patients with congestive heart failure","volume":"31","author":"Tsutamoto","year":"1998","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.clinbiochem.2013.10.025_bb0125","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1016\/0735-1097(95)00589-7","article-title":"Proinflammatory cytokine levels in patients with depressed left ventricular ejection fraction: A report from the studies of left ventricular dysfunction (solvd)","volume":"27","author":"Torre-Amione","year":"1996","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.clinbiochem.2013.10.025_bb0130","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/S0002-9149(98)00872-8","article-title":"Cytokine network in congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy","volume":"83","author":"Aukrust","year":"1999","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.clinbiochem.2013.10.025_bb0135","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1161\/01.CIR.93.4.704","article-title":"Tumor necrosis factor-\u03b1 and tumor necrosis factor receptors in the failing human heart","volume":"93","author":"Torre-Amione","year":"1996","journal-title":"Circulation"},{"key":"10.1016\/j.clinbiochem.2013.10.025_bb0140","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.ejheart.2003.10.004","article-title":"Transcardiac increase in tumor necrosis factor-\u03b1 and left ventricular end-diastolic volume in patients with dilated cardiomyopathy","volume":"6","author":"Tsutamoto","year":"2004","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.clinbiochem.2013.10.025_bb0145","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/S1479-666X(06)80004-1","article-title":"The molecular mechanisms of skeletal muscle wasting: Implications for therapy","volume":"4","author":"Skipworth","year":"2006","journal-title":"Surgeon"},{"key":"10.1016\/j.clinbiochem.2013.10.025_bb0150","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1097\/00000658-200101000-00003","article-title":"Muscle cachexia: Current concepts of intracellular mechanisms and molecular regulation","volume":"233","author":"Hasselgren","year":"2001","journal-title":"Ann Surg"},{"key":"10.1016\/j.clinbiochem.2013.10.025_bb0155","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1152\/physrev.00027.2001","article-title":"The ubiquitin\u2013proteasome proteolytic pathway: Destruction for the sake of construction","volume":"82","author":"Glickman","year":"2002","journal-title":"Physiol Rev"},{"key":"10.1016\/j.clinbiochem.2013.10.025_bb0160","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1046\/j.1365-2443.1997.1020301.x","article-title":"The n-end rule pathway of protein degradation","volume":"2","author":"Varshavsky","year":"1997","journal-title":"Genes Cells"},{"key":"10.1016\/j.clinbiochem.2013.10.025_bb0165","doi-asserted-by":"crossref","first-page":"12602","DOI":"10.1073\/pnas.95.21.12602","article-title":"Rates of ubiquitin conjugation increase when muscles atrophy, largely through activation of the n-end rule pathway","volume":"95","author":"Solomon","year":"1998","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.clinbiochem.2013.10.025_bb0170","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.cytogfr.2006.09.006","article-title":"Waste management\u2014cytokines, growth factors and cachexia","volume":"17","author":"Saini","year":"2006","journal-title":"Cytokine Growth Factor Rev"},{"key":"10.1016\/j.clinbiochem.2013.10.025_bb0175","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.ijcard.2011.09.079","article-title":"Metabolism and the heart: An overview of muscle, fat, and bone metabolism in heart failure","volume":"162","author":"Loncar","year":"2013","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.clinbiochem.2013.10.025_bb0180","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1006\/jmcc.1997.0592","article-title":"Interleukin-1 in myocardium and coronary arteries of patients with dilated cardiomyopathy","volume":"30","author":"Francis","year":"1998","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.clinbiochem.2013.10.025_bb0185","doi-asserted-by":"crossref","first-page":"6754","DOI":"10.1073\/pnas.86.17.6753","article-title":"Interleukin 1 and tumor necrosis factor inhibit cardiac myocyte \u00df-adrenergic responsiveness","volume":"86","author":"Gulick","year":"1989","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.clinbiochem.2013.10.025_bb0190","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1172\/JCI118653","article-title":"Endotoxin and cytokines induce expression of leptin, the ob gene product, in hamsters: A role for leptin in the anorexia of infection","volume":"97","author":"Grunfeld","year":"1996","journal-title":"J Clin Invest"},{"key":"10.1016\/j.clinbiochem.2013.10.025_bb0195","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/S0361-9230(97)00159-7","article-title":"Central nervous system il-1\u03b2 system and neuropeptide y mrnas during il-1\u03b2-induced anorexia in rats","volume":"44","author":"Gayle","year":"1997","journal-title":"Brain Res Bull"},{"key":"10.1016\/j.clinbiochem.2013.10.025_bb0200","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/0735-1097(92)90167-L","article-title":"The neurohormonal hypothesis: A theory to explain the mechanism of disease progression in heart failure","volume":"20","author":"Packer","year":"1992","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.clinbiochem.2013.10.025_bb0205","doi-asserted-by":"crossref","first-page":"D3","DOI":"10.1093\/ehjsupp\/4.suppl_D.D3","article-title":"Neurohormonal modulation in chronic heart failure","volume":"4","author":"Ferrara","year":"2002","journal-title":"Eur Heart J Suppl"},{"key":"10.1016\/j.clinbiochem.2013.10.025_bb0210","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.pharmthera.2004.04.004","article-title":"Implications of the natriuretic peptide system in the pathogenesis of heart failure: Diagnostic and therapeutic importance","volume":"102","author":"Abassi","year":"2004","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.clinbiochem.2013.10.025_bb0215","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0167-5273(02)00239-5","article-title":"Neurohormonal factors in the development of catabolic\/anabolic imbalance and cachexia","volume":"85","author":"Brink","year":"2002","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.clinbiochem.2013.10.025_bb0220","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1677\/JOE-07-0606","article-title":"Mechanisms of glucocorticoid-induced myopathy","volume":"197","author":"Schakman","year":"2008","journal-title":"J Endocrinol"},{"key":"10.1016\/j.clinbiochem.2013.10.025_bb0225","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1016\/S0735-1097(99)00495-7","article-title":"Effect of high- versus low-dose angiotensin converting enzyme inhibition on cytokine levels in chronic heart failure","volume":"34","author":"Gullestad","year":"1999","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.clinbiochem.2013.10.025_bb0230","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1056\/NEJM200105313442201","article-title":"Effect of carvedilol on survival in severe chronic heart failure","volume":"344","author":"Packer","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clinbiochem.2013.10.025_bb0235","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.drudis.2007.10.008","article-title":"Novel approaches to the treatment of cachexia","volume":"13","author":"Argil\u00e9s","year":"2008","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.clinbiochem.2013.10.025_bb0240","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/0014-2999(94)90229-1","article-title":"Megestrol acetate stimulates food and water intake in the rat: Effects on regional hypothalamic neuropeptide y concentrations","volume":"265","author":"McCarthy","year":"1994","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.clinbiochem.2013.10.025_bb0245","doi-asserted-by":"crossref","first-page":"499","DOI":"10.2165\/00003495-200161040-00004","article-title":"Managing cancer-related anorexia\/cachexia","volume":"61","author":"Mantovani","year":"2001","journal-title":"Drugs"},{"key":"10.1016\/j.clinbiochem.2013.10.025_bb0250","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1113\/jphysiol.1995.sp020880","article-title":"ffrench-Mullen JM. Residual ca2+ channel current modulation by megestrol acetate via a g-protein alpha s-subunit in rat hypothalamic neurones","volume":"487","author":"Costa","year":"1995","journal-title":"J Physiol"},{"key":"10.1016\/j.clinbiochem.2013.10.025_bb0255","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0162-3109(98)00041-1","article-title":"\u03949 tetrahydrocannabinol and cannabidiol alter cytokine production by human immune cells","volume":"40","author":"Srivastava","year":"1998","journal-title":"Immunopharmacology"},{"key":"10.1016\/j.clinbiochem.2013.10.025_bb0260","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/0192-0561(91)90160-9","article-title":"Marijuana components stimulate human peripheral blood mononuclear cell secretion of interferon-gamma and suppress interleukin-1 alpha in vitro","volume":"13","author":"Watzl","year":"1991","journal-title":"Int J Immunopharmacol"},{"key":"10.1016\/j.clinbiochem.2013.10.025_bb0265","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jjcc.2011.11.001","article-title":"Biochemical markers in heart failure","volume":"59","author":"Sato","year":"2012","journal-title":"J Cardiol"},{"key":"10.1016\/j.clinbiochem.2013.10.025_bb0270","article-title":"New biomarkers in heart failure: Applications in diagnosis, prognosis and guidance of therapy","volume":"63","author":"Richards","year":"2010","journal-title":"Rev Esp Cardiol"},{"key":"10.1016\/j.clinbiochem.2013.10.025_bb0275","doi-asserted-by":"crossref","first-page":"2388","DOI":"10.1093\/eurheartj\/ehn309","volume":"29","author":"Members","year":"2008","journal-title":"Eur Heart J"},{"key":"10.1016\/j.clinbiochem.2013.10.025_bb0280","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1093\/eurjhf\/hfp035","article-title":"Old and new biomarkers of heart failure","volume":"11","author":"Emdin","year":"2009","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.clinbiochem.2013.10.025_bb0285","first-page":"183","article-title":"Clinical impact of bnp and other emerging biomarkers in heart failure evaluation and management","volume":"60","author":"Palazzuoli","year":"2012","journal-title":"Minerva Cardioangiol"},{"key":"10.1016\/j.clinbiochem.2013.10.025_bb0290","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.ijcard.2008.11.149","article-title":"Natriuretic peptides and other biomarkers in chronic heart failure: From bnp, nt-probnp, and mr-proanp to routine biochemical markers","volume":"132","author":"Lainscak","year":"2009","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.clinbiochem.2013.10.025_bb0295","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1097\/01.hco.0000161832.04952.6a","article-title":"Novel markers for heart failure diagnosis and prognosis","volume":"20","author":"Lee","year":"2005","journal-title":"Curr Opin Cardiol"},{"key":"10.1016\/j.clinbiochem.2013.10.025_bb0300","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1038\/nature06802","article-title":"The search for new cardiovascular biomarkers","volume":"451","author":"Gerszten","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.clinbiochem.2013.10.025_bb0305","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/s10741-008-9123-9","article-title":"Biomarkers in heart failure: A clinical review","volume":"15","author":"Rocchiccioli","year":"2010","journal-title":"Heart Fail Rev"},{"key":"10.1016\/j.clinbiochem.2013.10.025_bb0310","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.1161\/hc4201.097836","article-title":"Elevated circulating level of ghrelin in cachexia associated with chronic heart failure","volume":"104","author":"Nagaya","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.clinbiochem.2013.10.025_bb0315","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1016\/0735-1097(95)00338-X","article-title":"Increased plasma levels of adrenomedullin in patients with heart failure","volume":"26","author":"Nishikimi","year":"1995","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.clinbiochem.2013.10.025_bb0320","first-page":"1834","article-title":"The plasma levels of dehydroepiandrosterone sulfate are decreased in patients with chronic heart failure in proportion to the severity","volume":"85","author":"Moriyama","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.clinbiochem.2013.10.025_bb0325","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.ijcard.2007.08.115","article-title":"Dehydroepiandrosterone levels vary according as heart failure condition in patients with idiopathic dilated cardiomyopathy","volume":"125","author":"Kawano","year":"2008","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.clinbiochem.2013.10.025_bb0330","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1093\/oxfordjournals.eurheartj.a015228","article-title":"Prognostic value of plasma endothelin-1 in patients with chronic heart failure","volume":"18","author":"Pousset","year":"1997","journal-title":"Eur Heart J"},{"key":"10.1016\/j.clinbiochem.2013.10.025_bb0335","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1161\/01.CIR.96.2.526","article-title":"Hormonal changes and catabolic\/anabolic imbalance in chronic heart failure and their importance for cardiac cachexia","volume":"96","author":"Anker","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/j.clinbiochem.2013.10.025_bb0340","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1053\/euhj.1999.1740","article-title":"Clinical implications of increased plasma angiotensin ii despite ace inhibitor therapy in patients with congestive heart failure","volume":"21","author":"Roig","year":"2000","journal-title":"Eur Heart J"},{"key":"10.1016\/j.clinbiochem.2013.10.025_bb0345","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1161\/CIRCULATIONAHA.106.653964","article-title":"Complementary and incremental mortality risk prediction by cortisol and aldosterone in chronic heart failure","volume":"115","author":"G\u00fcder","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.clinbiochem.2013.10.025_bb0350","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/S0002-9149(99)80231-8","article-title":"Prognostic value of plasma soluble intercellular adhesion molecule-1 and endothelin-1 concentration in patients with chronic congestive heart failure","volume":"76","author":"Tsutamoto","year":"1995","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.clinbiochem.2013.10.025_bb0355","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/S0735-1097(01)01385-7","article-title":"Acquired growth hormone resistance in patients with chronic heart failure: Implications for therapy with growth hormone","volume":"38","author":"Anker","year":"2001","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.clinbiochem.2013.10.025_bb0360","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1046\/j.1365-2796.1997.00209.x","article-title":"Proinflammatory cytokines, measured in a mixed population on arrival in the emergency department, are related to mortality and severity of disease","volume":"242","author":"Carlstedt","year":"1997","journal-title":"J Intern Med"},{"key":"10.1016\/j.clinbiochem.2013.10.025_bb0365","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1016\/S0735-1097(98)00101-6","article-title":"Increased oxidative stress in patients with congestive heart failure 1","volume":"31","author":"Keith","year":"1998","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.clinbiochem.2013.10.025_bb0370","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1056\/NEJM199102073240601","article-title":"The erythrocyte sedimentation rate in congestive heart failure","volume":"324","author":"Haber","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clinbiochem.2013.10.025_bb0375","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/S0735-1097(00)00745-2","article-title":"The relationship of the erythrocyte sedimentation rate to inflammatory cytokines and survival in patients with chronic heart failure treated with angiotensin-converting enzyme inhibitors","volume":"36","author":"Sharma","year":"2000","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.clinbiochem.2013.10.025_bb0380","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1161\/01.CIR.0000065637.10517.A0","article-title":"Uric acid and survival in chronic heart failure","volume":"107","author":"Anker","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.clinbiochem.2013.10.025_bb0385","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1067\/mhj.2001.114367","article-title":"Uric acid in cachectic and noncachectic patients with chronic heart failure: Relationship to leg vascular resistance","volume":"141","author":"Doehner","year":"2001","journal-title":"Am Heart J"}],"container-title":["Clinical Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009912013004992?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009912013004992?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T15:42:14Z","timestamp":1757864534000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009912013004992"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,1]]},"references-count":77,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2014,1]]}},"alternative-id":["S0009912013004992"],"URL":"https:\/\/doi.org\/10.1016\/j.clinbiochem.2013.10.025","relation":{},"ISSN":["0009-9120"],"issn-type":[{"value":"0009-9120","type":"print"}],"subject":[],"published":{"date-parts":[[2014,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Recent insights on the molecular mechanisms and therapeutic approaches for cardiac cachexia","name":"articletitle","label":"Article Title"},{"value":"Clinical Biochemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinbiochem.2013.10.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}